Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Intercommunal Creteil
About this trial
To evaluate the regenerative capacities of mesenchymal cells composing the microenvironment of alveolar type 2 cells in a population of patients, undergoing thoracic surgery for suspected cancer, who are smokers with and without COPD compared to non-smokers patients
Eligibility criteria
Qualifiers
Age ≥ 18
Patient undergoing lung resection surgery (lobectomy, pneumonectomy, segmentectomy) for cancer or suspected cancer
Acceptance to participate in the protocol
Affiliated to a social security plan
Disqualifiers
Chronic autoimmune disease
Patient under guardianship or curators
Neo-adjuvant chemotherapy
History of thoracic radiotherapy
Trial design
Treatments tested in this trial
- Thoracic resection surgery
Treatment groups
186 Participants
are divided into 1 treatment groupSponsors and collaborators
Centre Hospitalier Intercommunal Creteil
Lead sponsor
Henri Mondor University Hospital
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Source ClinicalTrials.gov